Claude designs protein binders for 14 out of 15 targets successfully
TinfoilTricorn · x · 2026-08-19
Anthropic announced that Claude has successfully achieved de novo protein design. Guided by a human-written prompt, Claude autonomously designed protein binders for 14 out of 15 targets.
The company partnered with Adaptyv Bio and Twist Bioscience to independently synthesize and test these designs, verifying that the AI-generated molecules effectively bind to their targets. This breakthrough could significantly shorten the drug discovery timeline, which traditionally takes weeks or months of expert work per target.
More from Research
- Neuroscience Research: Handwriting Activates Widespread Brain Connectivity — CurieuxExplorer · 2026-08-19
- Expert rebuts Anthropic: Binder design is not a drug proxy — rapha_gl · 2026-08-19
- Fun: Qwen Model Learns to 'Piggyback' on Walls in Snake Game — mervenoyann · 2026-08-19
- Study shows AI accelerating discoveries in Cyber and Math, but not Algorithms — eldonredwards · 2026-08-19
- Stanford CS25 lecture notes updated: From Tokenization to Transformers — tengyuma · 2026-08-19
- Differentiable Voxelization Links Surface and Volume Representations — ssh4net · 2026-08-19